STRATA Skin Sciences, Inc. (SSKN)

STRATA Skin Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	32.55	33.36	36.16	29.98	23.09	31.59
Revenue Growth (YoY)	-11.29%	-7.75%	20.63%	29.83%	-26.90%	5.80%
Cost of Revenue	15.39	14.9	14.39	10.13	8.96	11.32
Gross Profit	17.15	18.46	21.77	19.85	14.13	20.27
Selling, General & Admin	22.53	23.46	25.39	22.82	16.94	22.28
Research & Development	1.24	1.32	1.03	1.43	1.27	1
Other Operating Expenses	2.28	2.28	0	0	0	0
Operating Expenses	26.06	27.07	26.42	24.25	18.21	23.28
Operating Income	-8.91	-8.6	-4.65	-4.4	-4.08	-3.01
Interest Expense / Income	1.88	1.64	0.93	0.31	0.21	0.52
Other Expense / Income	0.67	0.68	-0.09	-2.04	-0.17	0.22
Pretax Income	-11.46	-10.92	-5.49	-2.67	-4.12	-3.75
Income Tax	-0.09	-0.09	0.06	0.03	0.28	-0.15
Net Income	-11.36	-10.83	-5.55	-2.71	-4.39	-3.6
Shares Outstanding (Basic)	4	3	3	3	3	3
Shares Outstanding (Diluted)	4	3	3	3	3	3
Shares Change	0.57%	0.60%	1.94%	1.31%	5.10%	63.25%
EPS (Basic)	-3.30	-3.10	-1.60	-0.80	-1.30	-1.10
EPS (Diluted)	-3.30	-3.10	-1.60	-0.80	-1.30	-1.10
Free Cash Flow	-4.46	-5.54	-4.66	-2.15	-0.06	-0.56
Free Cash Flow Per Share	-1.27	-1.59	-1.34	-0.63	-0.02	-0.18
Gross Margin	52.71%	55.34%	60.20%	66.22%	61.21%	64.17%
Operating Margin	-27.37%	-25.79%	-12.86%	-14.68%	-17.65%	-9.53%
Profit Margin	-34.91%	-32.47%	-15.35%	-9.03%	-19.03%	-11.39%
Free Cash Flow Margin	-13.70%	-16.60%	-12.89%	-7.16%	-0.27%	-1.78%
EBITDA	-3.83	-3.38	1.13	1.73	0	1.59
EBITDA Margin	-11.78%	-10.13%	3.12%	5.76%	0.01%	5.03%
Depreciation & Amortization	5.74	5.9	5.69	4.09	3.91	4.82
EBIT	-9.58	-9.28	-4.56	-2.36	-3.91	-3.23
EBIT Margin	-29.43%	-27.83%	-12.61%	-7.87%	-16.93%	-10.23%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).